US becomes first country in the world to approve gamechanger Alzheimer's drug lecanemab
The FDA has greenlit the drug developed by the Tokyo, Japan, company Eisai in partnership with America's Biogen. It slowed Alzheimer's by around 27 percent over 18 months.